Keeler Thomas Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$958K Buy
1,911
+129
+7% +$61.9K 0.34% 83
2026
Q1
$876K Sell
1,782
-244
-12% -$132K 0.37% 82
2025
Q4
$1.17M Sell
2,026
-10
-0.5% -$5.66K 0.56% 62
2025
Q3
$987K Buy
2,036
+97
+5% +$45.1K 0.4% 80
2025
Q2
$786K Buy
+1,939
New +$811K 0.34% 90
2023
Q2
Sell
-571
Closed -$329K 70
2023
Q1
$329K Sell
571
-426
-43% -$240K 0.15% 59
2022
Q4
$549K Sell
997
-1,114
-53% -$590K 0.28% 59
2022
Q3
$1.07M Buy
+2,111
New +$1.18M 0.54% 46
2022
Q2
Sell
-612
Closed -$361K 76
2022
Q1
$361K Sell
612
-7,152
-92% -$4.11M 0.17% 55
2021
Q4
$5.18M Buy
7,764
+146
+2% +$91.2K 2.24% 16
2021
Q3
$4.36M Buy
7,618
+113
+2% +$62K 2.07% 16
2021
Q2
$3.79M Buy
7,505
+817
+12% +$385K 1.85% 23
2021
Q1
$3.05M Buy
+6,688
New +$3.19M 1.61% 33
2018
Q1
Sell
-560
Closed -$106K 135
2017
Q4
$106K Buy
+560
New +$107K 0.1% 71

Other funds holding TMO

Keeler Thomas Management's TMO Position: Q2 2026 in Review

Keeler Thomas Management increased its Thermo Fisher Scientific (TMO) stake by 7.2% in Q2 2026, buying an estimated $61.9K and bringing the position to 1,911 shares worth $958K. The position accounts for 0.34% of the portfolio, ranked #83.

Keeler Thomas Management first reported a position in TMO in Q4 2017 and has held it in 14 quarters since. The position peaked at $5.18M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Keeler Thomas Management held 1,911 shares of Thermo Fisher Scientific worth $958K as of Q2 2026.
  • Keeler Thomas Management bought 129 Thermo Fisher Scientific shares in Q2 2026, an estimated $61.9K.
  • Thermo Fisher Scientific made up 0.34% of Keeler Thomas Management's portfolio in Q2 2026, its #83 holding.
  • Keeler Thomas Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 14 quarters since.
  • Keeler Thomas Management's Thermo Fisher Scientific position peaked at $5.18M in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Keeler Thomas Management's 13F filing for Q2 2026, filed 30 Jul 2026.